Precigen PGEN
NASDAQ PGEN
$8.56 +0.51 (+6.33%)
As of: Sep 30, 2026 · 3:59 PM EDT

Precigen (PGEN) Receivables - Accured (2022)

Updated

Precigen (PGEN) recorded Receivables - Accured of $24,000 in Q1 2022.

Analysis

Precigen (PGEN) Receivables - Accured (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Precigen 2.88 Bn 2.88 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 24,000.00
API Access

Precigen Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=PGEN&period=max&api_key=YOUR_API_KEY